pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-NIG-2023-04401 | Nigeria | 2,023 | Regional | Cervix | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Present | Negative | Positive | Negative | Negative | 57.0 | Negative | null | Resection | Yes | 7 | moderate_burden |
PATH-UGA-2023-04402 | Uganda | 2,023 | Regional | Cervix | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Present | Close | Positive | Positive | Negative | 13.1 | Negative | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-UGA-2021-04403 | Uganda | 2,021 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Not documented | Not applicable | Negative | Positive | Negative | 43.4 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-NIG-2025-04404 | Nigeria | 2,025 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Positive | 14.7 | Negative | null | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-TAN-2019-04405 | Tanzania | 2,019 | District | Colorectal | 8310/3 | Clear cell carcinoma | Undifferentiated | Not documented | Absent | Not applicable | Positive | Positive | Negative | 87.5 | Negative | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-GHA-2025-04406 | Ghana | 2,025 | District | Stomach | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Positive | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-NIG-2022-04407 | Nigeria | 2,022 | National referral | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-TAN-2023-04408 | Tanzania | 2,023 | District | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-TAN-2019-04409 | Tanzania | 2,019 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Positive | Positive | Positive | Negative | 65.7 | Positive | null | Excisional biopsy | No - inconclusive | 14 | moderate_burden |
PATH-KEN-2022-04410 | Kenya | 2,022 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Close | Positive | Positive | Positive | 52.6 | Negative | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-ETH-2025-04411 | Ethiopia | 2,025 | National referral | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Not done | Negative | 77.4 | Positive | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-TAN-2020-04412 | Tanzania | 2,020 | Regional | Lung | 8500/3 | Ductal carcinoma | Undifferentiated | Not documented | Present | Negative | Positive | Negative | Negative | 28.4 | Not done | null | Resection | No - inconclusive | 15 | moderate_burden |
PATH-TAN-2020-04413 | Tanzania | 2,020 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Close | Negative | Positive | Negative | 69.6 | Positive | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-ETH-2019-04414 | Ethiopia | 2,019 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Not applicable | Negative | Negative | Negative | 7.1 | Negative | null | Fine needle aspirate | No - inconclusive | 14 | moderate_burden |
PATH-ETH-2021-04415 | Ethiopia | 2,021 | National referral | Thyroid | 8310/3 | Clear cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Negative | Positive | 9.1 | Negative | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-GHA-2020-04416 | Ghana | 2,020 | District | Liver | 8720/3 | Melanoma | Well differentiated | Present | Not documented | Positive | Positive | Negative | Negative | 80.8 | Negative | null | Resection | Yes | 26 | moderate_burden |
PATH-ETH-2023-04417 | Ethiopia | 2,023 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Present | Negative | Not done | Negative | Negative | 87.3 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-NIG-2019-04418 | Nigeria | 2,019 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Positive | Equivocal | 37.4 | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-ETH-2023-04419 | Ethiopia | 2,023 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Negative | Negative | 86.7 | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-SOU-2018-04420 | South Africa | 2,018 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Positive | Positive | Positive | Negative | 20.9 | Negative | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-GHA-2022-04421 | Ghana | 2,022 | Regional | Cervix | 8260/3 | Papillary carcinoma | Well differentiated | Present | Absent | Positive | Negative | Positive | Negative | 80.1 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2025-04422 | Tanzania | 2,025 | National referral | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Negative | Negative | 58.2 | Not done | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-UGA-2024-04423 | Uganda | 2,024 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Negative | Positive | Positive | Negative | 33.3 | Negative | null | Excisional biopsy | No - suboptimal | 3 | moderate_burden |
PATH-ETH-2025-04424 | Ethiopia | 2,025 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Negative | Positive | Not done | Negative | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-KEN-2020-04425 | Kenya | 2,020 | National referral | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 23.3 | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-GHA-2023-04426 | Ghana | 2,023 | Regional | Bladder | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Not done | Not done | Positive | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-NIG-2020-04427 | Nigeria | 2,020 | National referral | Cervix | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Negative | Not done | Negative | Not done | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-GHA-2019-04428 | Ghana | 2,019 | District | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Positive | null | Resection | Yes | 6 | moderate_burden |
PATH-SOU-2024-04429 | South Africa | 2,024 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 15 | moderate_burden |
PATH-GHA-2021-04430 | Ghana | 2,021 | Regional | Breast | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Positive | Triple negative | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-GHA-2024-04431 | Ghana | 2,024 | District | Colorectal | 8510/3 | Medullary carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Negative | Negative | Negative | 43.4 | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-ETH-2022-04432 | Ethiopia | 2,022 | National referral | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 45.3 | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2018-04433 | Nigeria | 2,018 | Regional | Thyroid | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Absent | Not applicable | Positive | Positive | Negative | 87.3 | Positive | null | Excisional biopsy | No - inconclusive | 17 | moderate_burden |
PATH-KEN-2019-04434 | Kenya | 2,019 | Regional | Prostate | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Not documented | Not applicable | Not done | Positive | Negative | 34.2 | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2023-04435 | Uganda | 2,023 | National referral | Liver | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Present | Close | Negative | Positive | Negative | 20.8 | Negative | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2021-04436 | Tanzania | 2,021 | National referral | Ovary | 8720/3 | Melanoma | Poorly differentiated | Present | Not documented | Negative | Negative | Positive | Positive | 39.1 | Positive | null | Fine needle aspirate | Yes | 16 | moderate_burden |
PATH-SOU-2024-04437 | South Africa | 2,024 | District | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2024-04438 | Tanzania | 2,024 | District | Lung | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Close | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-NIG-2023-04439 | Nigeria | 2,023 | National referral | Prostate | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Negative | Not done | 28.8 | Positive | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-SOU-2019-04440 | South Africa | 2,019 | Regional | Stomach | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Not done | 81.4 | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-TAN-2020-04441 | Tanzania | 2,020 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Positive | Not done | Negative | Negative | 62.7 | Negative | Luminal A | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-SOU-2024-04442 | South Africa | 2,024 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Positive | Not done | Positive | Negative | 35.7 | Positive | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-NIG-2022-04443 | Nigeria | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Negative | Positive | 43.8 | Negative | null | Resection | No - inconclusive | 17 | moderate_burden |
PATH-NIG-2018-04444 | Nigeria | 2,018 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Not done | 9.1 | Not done | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-GHA-2025-04445 | Ghana | 2,025 | National referral | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Positive | Negative | Positive | Negative | 61.5 | Negative | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-ETH-2018-04446 | Ethiopia | 2,018 | Regional | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Equivocal | 79.0 | Negative | null | Core needle biopsy | No - inconclusive | 7 | moderate_burden |
PATH-ETH-2023-04447 | Ethiopia | 2,023 | District | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Present | Negative | Negative | Positive | Negative | 75.7 | Positive | null | Core needle biopsy | No - inconclusive | 5 | moderate_burden |
PATH-UGA-2018-04448 | Uganda | 2,018 | Regional | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Close | Negative | Negative | Equivocal | 7.4 | Negative | Luminal B | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-GHA-2024-04449 | Ghana | 2,024 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Positive | Positive | 53.1 | Negative | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2019-04450 | Nigeria | 2,019 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Close | Negative | Negative | Negative | 56.9 | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-KEN-2019-04451 | Kenya | 2,019 | District | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Not done | 78.1 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-KEN-2024-04452 | Kenya | 2,024 | Regional | Stomach | 8500/3 | Ductal carcinoma | Well differentiated | Present | Not documented | Negative | Negative | Not done | Positive | 49.9 | Positive | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-UGA-2024-04453 | Uganda | 2,024 | District | Stomach | 8260/3 | Papillary carcinoma | Undifferentiated | Not documented | Not documented | Negative | Negative | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-NIG-2018-04454 | Nigeria | 2,018 | Regional | Lung | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Not done | 46.7 | Positive | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2022-04455 | Nigeria | 2,022 | Regional | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 71.9 | Positive | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-GHA-2023-04456 | Ghana | 2,023 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 59.5 | Negative | null | Resection | Yes | 22 | moderate_burden |
PATH-NIG-2025-04457 | Nigeria | 2,025 | District | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-KEN-2023-04458 | Kenya | 2,023 | Regional | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Positive | Negative | 8.6 | Negative | Luminal A | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-TAN-2019-04459 | Tanzania | 2,019 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | 36.1 | Negative | null | Resection | Yes | 11 | moderate_burden |
PATH-ETH-2021-04460 | Ethiopia | 2,021 | District | Bladder | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Positive | 40.5 | Negative | null | Resection | Yes | 5 | moderate_burden |
PATH-TAN-2018-04461 | Tanzania | 2,018 | District | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Positive | Negative | Negative | Not done | Not done | null | Fine needle aspirate | Yes | 23 | moderate_burden |
PATH-TAN-2024-04462 | Tanzania | 2,024 | Regional | Breast | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Positive | Negative | 24.8 | Positive | Luminal B | Resection | No - inconclusive | 27 | moderate_burden |
PATH-KEN-2025-04463 | Kenya | 2,025 | National referral | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 25.1 | Positive | null | Fine needle aspirate | Yes | 8 | moderate_burden |
PATH-TAN-2022-04464 | Tanzania | 2,022 | Regional | Cervix | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Not documented | Positive | Positive | Negative | Negative | 85.7 | Not done | null | Resection | No - suboptimal | 8 | moderate_burden |
PATH-UGA-2024-04465 | Uganda | 2,024 | District | Liver | 8720/3 | Melanoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Negative | Equivocal | Not done | Negative | null | Resection | Yes | 27 | moderate_burden |
PATH-SOU-2020-04466 | South Africa | 2,020 | Regional | Lung | 8500/3 | Ductal carcinoma | Well differentiated | Present | Absent | Negative | Negative | Positive | Positive | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2021-04467 | Ghana | 2,021 | Regional | Liver | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Positive | 66.4 | Positive | null | Resection | Yes | 3 | moderate_burden |
PATH-GHA-2021-04468 | Ghana | 2,021 | District | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Positive | Negative | 58.9 | Positive | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-UGA-2019-04469 | Uganda | 2,019 | National referral | Prostate | 8510/3 | Medullary carcinoma | Well differentiated | Absent | Not documented | Negative | Positive | Positive | Positive | 32.6 | Positive | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2020-04470 | Tanzania | 2,020 | District | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Not documented | Close | Positive | Positive | Negative | Not done | Positive | null | Resection | Yes | 18 | moderate_burden |
PATH-UGA-2019-04471 | Uganda | 2,019 | District | Lung | 8310/3 | Clear cell carcinoma | Undifferentiated | Present | Not documented | Close | Positive | Negative | Negative | Not done | Positive | null | Resection | Yes | 25 | moderate_burden |
PATH-NIG-2025-04472 | Nigeria | 2,025 | District | Cervix | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Present | Not documented | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 14 | moderate_burden |
PATH-SOU-2022-04473 | South Africa | 2,022 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 7.5 | Negative | null | Core needle biopsy | No - inconclusive | 22 | moderate_burden |
PATH-NIG-2022-04474 | Nigeria | 2,022 | National referral | Liver | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | 72.2 | Negative | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-GHA-2022-04475 | Ghana | 2,022 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Negative | Not done | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-KEN-2024-04476 | Kenya | 2,024 | Regional | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Close | Positive | Positive | Negative | 17.8 | Negative | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-NIG-2018-04477 | Nigeria | 2,018 | District | Liver | 8140/3 | Adenocarcinoma | Well differentiated | Not documented | Not documented | Close | Positive | Positive | Not done | Not done | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2023-04478 | Nigeria | 2,023 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 70.7 | Positive | null | Fine needle aspirate | Yes | 6 | moderate_burden |
PATH-NIG-2018-04479 | Nigeria | 2,018 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Negative | Negative | 37.2 | Positive | null | Excisional biopsy | No - inconclusive | 12 | moderate_burden |
PATH-KEN-2019-04480 | Kenya | 2,019 | National referral | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Positive | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-KEN-2024-04481 | Kenya | 2,024 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Present | Negative | Negative | Not done | Negative | 43.9 | Negative | null | Fine needle aspirate | Yes | 11 | moderate_burden |
PATH-ETH-2018-04482 | Ethiopia | 2,018 | District | Stomach | 8140/3 | Adenocarcinoma | Well differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 62.2 | Negative | null | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-ETH-2019-04483 | Ethiopia | 2,019 | National referral | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Not done | Negative | 53.8 | Positive | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2024-04484 | Kenya | 2,024 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Not done | Not done | Positive | null | Fine needle aspirate | Yes | 21 | moderate_burden |
PATH-NIG-2023-04485 | Nigeria | 2,023 | District | Breast | 8310/3 | Clear cell carcinoma | Moderately differentiated | Not documented | Not documented | Not applicable | Positive | Positive | Negative | Not done | Positive | Triple negative | Resection | Yes | 13 | moderate_burden |
PATH-UGA-2025-04486 | Uganda | 2,025 | District | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Positive | Equivocal | Not done | Positive | null | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-KEN-2020-04487 | Kenya | 2,020 | District | Ovary | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 57.0 | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2020-04488 | Nigeria | 2,020 | District | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Close | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-SOU-2021-04489 | South Africa | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Negative | Positive | Positive | Positive | 86.6 | Positive | Luminal A | Resection | No - suboptimal | 9 | moderate_burden |
PATH-KEN-2020-04490 | Kenya | 2,020 | National referral | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 43.8 | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-SOU-2018-04491 | South Africa | 2,018 | District | Prostate | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Present | Negative | Not done | Negative | Equivocal | 73.4 | Negative | null | Resection | Yes | 16 | moderate_burden |
PATH-GHA-2023-04492 | Ghana | 2,023 | Regional | Stomach | 8890/3 | Leiomyosarcoma | Undifferentiated | Absent | Absent | Negative | Negative | Negative | Positive | Not done | Negative | null | Core needle biopsy | No - inconclusive | 9 | moderate_burden |
PATH-TAN-2023-04493 | Tanzania | 2,023 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Not done | Not done | 27.7 | Negative | null | Fine needle aspirate | No - inconclusive | 12 | moderate_burden |
PATH-SOU-2022-04494 | South Africa | 2,022 | District | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Present | Close | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2019-04495 | South Africa | 2,019 | District | Stomach | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Not done | Positive | 43.2 | Positive | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-SOU-2018-04496 | South Africa | 2,018 | National referral | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 87.8 | Not done | null | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2022-04497 | South Africa | 2,022 | Regional | Thyroid | 8310/3 | Clear cell carcinoma | Well differentiated | Absent | Absent | Negative | Not done | Negative | Negative | 72.9 | Positive | null | Core needle biopsy | No - inconclusive | 4 | moderate_burden |
PATH-ETH-2021-04498 | Ethiopia | 2,021 | District | Lung | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 85.0 | Not done | null | Resection | Yes | 23 | moderate_burden |
PATH-KEN-2019-04499 | Kenya | 2,019 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Positive | Not done | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-GHA-2020-04500 | Ghana | 2,020 | Regional | Stomach | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.